Free Trial

Premier (PINC) Competitors

Premier logo
$22.23 -0.07 (-0.31%)
(As of 11/20/2024 ET)

PINC vs. EVH, FC, MANT, TMX, RCM, MARA, BILI, LYFT, QXO, and ETSY

Should you be buying Premier stock or one of its competitors? The main competitors of Premier include Evolent Health (EVH), Franklin Covey (FC), ManTech International (MANT), Terminix Global (TMX), R1 RCM (RCM), MARA (MARA), Bilibili (BILI), Lyft (LYFT), QXO (QXO), and Etsy (ETSY).

Premier vs.

Evolent Health (NYSE:EVH) and Premier (NASDAQ:PINC) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, community ranking, valuation, profitability, dividends, media sentiment, risk and earnings.

Evolent Health has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500. Comparatively, Premier has a beta of 0.4, meaning that its share price is 60% less volatile than the S&P 500.

In the previous week, Evolent Health had 4 more articles in the media than Premier. MarketBeat recorded 9 mentions for Evolent Health and 5 mentions for Premier. Premier's average media sentiment score of 0.74 beat Evolent Health's score of 0.18 indicating that Premier is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Evolent Health
4 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral
Premier
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

74.4% of Premier shares are owned by institutional investors. 1.6% of Evolent Health shares are owned by company insiders. Comparatively, 1.0% of Premier shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Premier has lower revenue, but higher earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Premier, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evolent Health$2.46B0.54-$113.04M-$0.91-12.53
Premier$1.35B1.59$119.54M$1.3616.35

Premier has a net margin of 11.41% compared to Evolent Health's net margin of -2.93%. Premier's return on equity of 10.74% beat Evolent Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Evolent Health-2.93% 6.30% 2.57%
Premier 11.41%10.74%6.36%

Evolent Health presently has a consensus target price of $28.90, suggesting a potential upside of 153.51%. Premier has a consensus target price of $21.36, suggesting a potential downside of 3.93%. Given Evolent Health's stronger consensus rating and higher possible upside, research analysts clearly believe Evolent Health is more favorable than Premier.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Evolent Health
0 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
3.00
Premier
0 Sell rating(s)
9 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Premier received 55 more outperform votes than Evolent Health when rated by MarketBeat users. However, 74.30% of users gave Evolent Health an outperform vote while only 68.19% of users gave Premier an outperform vote.

CompanyUnderperformOutperform
Evolent HealthOutperform Votes
558
74.30%
Underperform Votes
193
25.70%
PremierOutperform Votes
613
68.19%
Underperform Votes
286
31.81%

Summary

Premier beats Evolent Health on 10 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PINC vs. The Competition

MetricPremierManagement services IndustryMedical SectorNASDAQ Exchange
Market Cap$2.14B$7.82B$5.07B$8.90B
Dividend Yield3.77%3.31%4.99%4.07%
P/E Ratio16.3510.6987.8613.46
Price / Sales1.592.201,228.8287.66
Price / Cash6.1315.5239.5136.27
Price / Book1.098.446.946.30
Net Income$119.54M$156.61M$119.12M$225.93M
7 Day Performance-2.29%-3.72%-1.84%-1.32%
1 Month Performance11.88%-8.26%-3.65%0.60%
1 Year Performance5.21%-5.34%31.64%26.23%

Premier Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PINC
Premier
3.2124 of 5 stars
$22.23
-0.3%
$21.36
-3.9%
+5.7%$2.14B$1.35B16.352,900
EVH
Evolent Health
3.5821 of 5 stars
$11.40
+0.8%
$28.90
+153.5%
-61.3%$1.33B$2.46B-12.414,700Analyst Forecast
FC
Franklin Covey
4.1727 of 5 stars
$35.48
+0.5%
$63.33
+78.5%
-10.0%$467.63M$287.23M20.281,084Short Interest ↓
MANT
ManTech International
N/A$95.98
flat
N/A+0.0%$3.93B$2.55B32.329,800
TMX
Terminix Global
0.3916 of 5 stars
$37.87
flat
N/AN/A$4.61B$2.05B71.4511,700
RCM
R1 RCM
3.181 of 5 stars
$14.31
flat
$15.41
+7.7%
N/A$6.04B$2.25B0.0030,000News Coverage
MARA
MARA
2.7505 of 5 stars
$24.42
+7.9%
$22.57
-7.6%
+112.7%$7.86B$387.51M28.659Analyst Forecast
Insider Trade
Options Volume
Gap Up
BILI
Bilibili
2.2522 of 5 stars
$18.80
-2.0%
$19.69
+4.7%
+31.7%$7.79B$3.19B-20.868,801Earnings Report
Analyst Forecast
Gap Up
LYFT
Lyft
3.9777 of 5 stars
$16.71
-0.4%
$17.48
+4.6%
+61.4%$6.93B$4.40B0.002,945
QXO
QXO
0.9892 of 5 stars
$15.99
+0.6%
N/AN/A$6.55B$54.52M-1.75195News Coverage
ETSY
Etsy
4.6099 of 5 stars
$50.95
+0.2%
$64.87
+27.3%
-29.4%$5.73B$2.75B25.952,420

Related Companies and Tools


This page (NASDAQ:PINC) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners